This site is intended for healthcare professionals
News

EU approves new IV formulation of Ultomiris for paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.- Alexion Pharma

Read time: 1 mins
Last updated:21th Nov 2020
Published:21th Nov 2020
Condition: Paroxysmal Nocturnal Haemoglobinuria
Type: drug
Register free for full access to medthority.com